Cellular and molecular chaperone fusion vaccines: Targeting resistant cancer cell populations

References

• Ellis RJ. Protein misassembly: Macromolecular crowding and molecular chaperones. Adv Exp Med Biol 2007;594:1–13
   PubMed Web of Science ®Google Scholar
• Lindquist S, Craig EA. The heat shock proteins. Ann Rev Genet 1988;22:631–7
   PubMed Web of Science ®Google Scholar
• Murshid A, Gong J, Stevenson MA, Calderwood SK. Heat shock proteins and cancer vaccines: Developments in the past decade and chaperoning in the decade to come. Expert Rev Vaccines 2011;10:1553–68
   PubMed Web of Science ®Google Scholar
• Craig EA. The stress response: Changes in eukaryotic gene expression in response to environmental stress. Science 1985;230:800–1
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Arrigo AP, Calderwood SK. Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: An update. Arch Toxicol 2013;87:19–48
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Calderwood SK. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005;10:86–103
   PubMed Web of Science ®Google Scholar
• Calderwood SK. Heat shock proteins in breast cancer progression – A suitable case for treatment? Int J Hyperthermia 2010;26:681–5
   PubMed Web of Science ®Google Scholar
• Neckers L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 2002;8:S55–61
   PubMed Web of Science ®Google Scholar
• Trepel J, Mollapour M, Giaccone G, Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 2010;10:537–49
   PubMed Web of Science ®Google Scholar
• Neckers L, Workman P. Hsp90 molecular chaperone inhibitors: Are we there yet? Clin Cancer Res 2012;18:64–76
   PubMed Web of Science ®Google Scholar
• Powers MV, Jones K, Barillari C, Westwood I, van Montfort RL, Workman P. Targeting HSP70: The second potentially druggable heat shock protein and molecular chaperone? Cell Cycle 2011;9:1542–50
   Web of Science ®Google Scholar
• Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 1993;178:1391–6
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Ciocca DR. Heat shock proteins: Stress proteins with Janus-like properties in cancer. Int J Hyperthermia 2008;24:31–9
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Theriault JR, Gong J. Message in a bottle: Role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol 2005;35:2518–27
   PubMed Web of Science ®Google Scholar
• Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002;20:395–425
   PubMed Web of Science ®Google Scholar
• Murshid A, Gong J, Calderwood SK. Purification, preparation, and use of chaperone-peptide complexes for tumor immunotherapy. Methods Mol Biol 2013;960:209–17
   PubMedGoogle Scholar
• Singh-Jasuja H, Toes RE, Spee P, Munz C, Hilf N, Schoenberger SP, et al. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 2000;191:1965–74
   PubMed Web of Science ®Google Scholar
• Wang XY, Kazim L, Repasky EA, Subjeck JR. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease. Int J Cancer 2003;105:226–31
   PubMed Web of Science ®Google Scholar
• Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 2001;166:490–7
   PubMed Web of Science ®Google Scholar
• Enomoto Y, Bharti A, Khaleque AA, Song B, Liu C, Apostolopoulos V, et al. Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. J Immunol 2006;177:5946–55
   PubMed Web of Science ®Google Scholar
• Arnouk H, Zynda ER, Wang XY, Hylander BL, Manjili MH, Repasky EA, et al. Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo. Int J Hyperthermia 2010;26:366–75
   PubMed Web of Science ®Google Scholar
• Srivastava PK. Therapeutic cancer vaccines. Curr Opin Immunol 2006;18:201–5
   PubMed Web of Science ®Google Scholar
• Wang XY, Sun X, Chen X, Facciponte J, Repasky EA, Kane J, et al. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen. J Immunol 2011;184:6309–19
   Web of Science ®Google Scholar
• Weng D, Calderwood SK, Gong J. Preparation of a heat shock protein-based vaccine from dendritic cells. Methods Mol Biol 2011;787:255–65
   PubMedGoogle Scholar
• Weng D, Song B, Durfee J, Sugiyama V, Wu Z, Koido S, et al. Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells. Int J Cancer 2010;129:1990–2001
   Web of Science ®Google Scholar
• Gong J, Zhang Y, Durfee J, Weng D, Liu C, Koido S, et al. A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use. J Immunol 2010;184:488–96
   PubMed Web of Science ®Google Scholar
• Kunisawa J, Shastri N. Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 2006;24:523–34
   PubMed Web of Science ®Google Scholar
• Murshid A, Gong J, Calderwood SK. Heat shock protein 90 mediates efficient antigen cross presentation through the scavenger receptor expressed by endothelial cells-I. J Immunol 2010;185:2903–17
   PubMed Web of Science ®Google Scholar
• Hall EJ. Radiobiology for the Radiologist. Philadelphia: Lippincott-Raven; 1993
   Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105–11
   PubMed Web of Science ®Google Scholar
• Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009;23:2563–77
   PubMed Web of Science ®Google Scholar
• Phillips TM, McBride WH, Pajonk F. The response of CD24(−/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777–85
   PubMed Web of Science ®Google Scholar
• Schatton T, Schutte U, Frank NY, Zhan Q, Hoerning A, Robles SC, et al. Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res 2010;70:697–708
   PubMed Web of Science ®Google Scholar
• Schatton T, Frank MH. Antitumor immunity and cancer stem cells. Ann NY Acad Sci 2009;1176:154–69
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Stevenson MA, Murshid A. Heat shock proteins, autoimmunity, and cancer treatment. Autoimmune Dis 2012;2012:486069, 1–10
   PubMedGoogle Scholar
• Mantovani A. Cancer: Inflaming metastasis. Nature 2009;457:36–7
   PubMed Web of Science ®Google Scholar
• Charafe-Jauffret E, Ginestier C, Birnbaum D. Breast cancer stem cells: Tools and models to rely on. BMC Cancer 2009;9:202
   PubMed Web of Science ®Google Scholar
• Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 2009;8:158–66
   PubMed Web of Science ®Google Scholar
• Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008;68:4311–20
   PubMed Web of Science ®Google Scholar
• Weng D, Penzner JH, Song B, Koido S, Calderwood SK, Gong J. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Breast Cancer Res 2012;14:R18
   PubMed Web of Science ®Google Scholar
• Ho JN, Kang GY, Lee SS, Kim J, Bae IH, Hwang SG, et al. Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells. Cancer Sci 2010;101:1417–23
   PubMed Web of Science ®Google Scholar
• Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F. Radiation-induced reprogramming of breast cancer cells. Stem Cells 2012;30:833–44
   PubMed Web of Science ®Google Scholar
• Welstead GG, Brambrink T, Jaenisch R. Generating iPS cells from MEFS through forced expression of Sox-2, Oct-4, c-Myc, and Klf4. J Vis Exp 2008;14:734
   Google Scholar
• Kottke T, Sanchez-Perez L, Diaz RM, Thompson J, Chong H, Harrington K, et al. Induction of Hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res 2007;67:11970–9
   PubMed Web of Science ®Google Scholar
• McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, et al. A sense of danger from radiation. Radiat Res 2004;162:1–19
   PubMed Web of Science ®Google Scholar
• Vissers JH, van Lohuizen M, Citterio E. The emerging role of Polycomb repressors in the response to DNA damage. J Cell Sci 2012;125:3939–48
   PubMed Web of Science ®Google Scholar
• Vlashi E, McBride WH, Pajonk F. Radiation responses of cancer stem cells. J Cell Biochem 2009;108:339–42
   PubMed Web of Science ®Google Scholar
• Calderwood SK. Hyperthermia, the tumor microenvironment and immunity. In: Kelsari, Y, ed. Tumor Ablation, The Tumor Microenvironment. Volume 5. Dordrecht: Springer, 2012, pp. 29--37
   Google Scholar
• Mambula SS, Calderwood SK. Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. Int J Hyperthermia 2006;22:575–85
   PubMed Web of Science ®Google Scholar
• Srivastava P. Hypothesis: Controlled necrosis as a tool for immunotherapy of human cancer. Cancer Immun 2003;3:4
   PubMedGoogle Scholar
• Segal BH, Wang XY, Dennis CG, Youn R, Repasky EA, Manjili MH, et al. Heat shock proteins as vaccine adjuvants in infections and cancer. Drug Discov Today 2006;11:534–40
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: Moving beyond current vaccines. Nature Med 2004;10:909–15
   PubMed Web of Science ®Google Scholar
• Rosenberg SA. Shedding light on tumor immunotherapy of cancer. New Engl J Med 2004;350:1461–63
   PubMed Web of Science ®Google Scholar